Your browser doesn't support javascript.
loading
High frequency of cytolytic 21-hydroxylase-specific CD8+ T cells in autoimmune Addison's disease patients.
Dawoodji, Amina; Chen, Ji-Li; Shepherd, Dawn; Dalin, Frida; Tarlton, Andrea; Alimohammadi, Mohammad; Penna-Martinez, Marissa; Meyer, Gesine; Mitchell, Anna L; Gan, Earn H; Bratland, Eirik; Bensing, Sophie; Husebye, Eystein S; Pearce, Simon H; Badenhoop, Klaus; Kämpe, Olle; Cerundolo, Vincenzo.
Afiliación
  • Dawoodji A; Medical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DU, United Kingdom;
  • Chen JL; Medical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DU, United Kingdom;
  • Shepherd D; Medical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DU, United Kingdom;
  • Dalin F; Centre of Molecular Medicine, Department of Medicine (Solna), Karolinska Institutet, 171 76 Stockholm, Sweden;
  • Tarlton A; Medical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DU, United Kingdom;
  • Alimohammadi M; Centre of Molecular Medicine, Department of Medicine (Solna), Karolinska Institutet, 171 76 Stockholm, Sweden;
  • Penna-Martinez M; Division of Endocrinology, University Hospital Frankfurt, 60590 Frankfurt am Main, Germany;
  • Meyer G; Division of Endocrinology, University Hospital Frankfurt, 60590 Frankfurt am Main, Germany;
  • Mitchell AL; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne NE1 3BZ, United Kingdom;
  • Gan EH; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne NE1 3BZ, United Kingdom;
  • Bratland E; Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway; Department of Medicine, Haukeland University Hospital, 5021 Bergen, Norway;
  • Bensing S; Centre of Molecular Medicine, Department of Medicine (Solna), Karolinska Institutet, 171 76 Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, SE-171 77 Stockholm, Sweden; and.
  • Husebye ES; Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway; Department of Medicine, Haukeland University Hospital, 5021 Bergen, Norway;
  • Pearce SH; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne NE1 3BZ, United Kingdom;
  • Badenhoop K; Division of Endocrinology, University Hospital Frankfurt, 60590 Frankfurt am Main, Germany;
  • Kämpe O; Centre of Molecular Medicine, Department of Medicine (Solna), Karolinska Institutet, 171 76 Stockholm, Sweden; Science for Life Laboratory, Uppsala University 750 03, Uppsala, Sweden.
  • Cerundolo V; Medical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DU, United Kingdom; vincenzo.cerundolo@imm.ox.ac.uk.
J Immunol ; 193(5): 2118-26, 2014 Sep 01.
Article en En | MEDLINE | ID: mdl-25063864
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Péptidos / Enfermedad de Addison / Esteroide 21-Hidroxilasa / Linfocitos T CD8-positivos / Proliferación Celular / Inmunidad Celular Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Humans / Middle aged Idioma: En Revista: J Immunol Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Péptidos / Enfermedad de Addison / Esteroide 21-Hidroxilasa / Linfocitos T CD8-positivos / Proliferación Celular / Inmunidad Celular Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Humans / Middle aged Idioma: En Revista: J Immunol Año: 2014 Tipo del documento: Article